1. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. (December 2021) Authors: Burns, Jane C; Roberts, Samantha C; Tremoulet, Adriana H; He, Feng; Printz, Beth F; Ashouri, Negar; Jain, Supriya S; Michalik, David E; Sharma, Kavita; Truong, Dongngan T; Wood, James B; Kim, Katherine K; Jain, Sonia; Anand, Vikram; Anderson, Marsha; Ang, Jocelyn; Ansusinha, Emily; Arditi, Moshe;... Journal: Lancet Issue: Volume 5:Number 12(2021) Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗